Skip to content

In Silico Study of Primary Dysmenorrhea Using remedies From Synthesis Repertory

In Silico And Clinical Validation Of Graded Remedies From Synthesis Repertory For Primary Dysmenorrhea - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095365
Enrollment
30
Registered
2025-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: Individualized homoeopathic remedies selected from synthesis Repertory for primary dysmenorrhea.: Patients will receive individualized homoeopathic remedies selected from the Synthesis

Sponsors

DR Nancy Vashista
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Remedies which were prepared from plants will be taken. 2 Only secondary metabolites of the plant will be included. 3 Proteins with UniProt ID only will be included. 4 For Molecular docking hub protein with MCC value greater than 70 be included.

Exclusion criteria

Exclusion criteria: 1 Remedies that are not prepared from a plant. 2 Phytochemicals that are not primary metabolites. 3 Proteins that don t have a UniProt ID. 4 Proteins have MCC value lesser than 70.

Design outcomes

Primary

MeasureTime frame
Change in VAS pain score after 3 cyclesTimepoint: 5 followups, during every menstrual cycle, every month

Secondary

MeasureTime frame
Improvement in quality-of-life scores (MDQ) 16Timepoint: 5 followups, during every menstrual cycle, every month;Number of pain-free or low-pain cyclesTimepoint: 5 followups, during every menstrual cycle, every month

Countries

India

Contacts

Public ContactDR Rajendra E Shinde

Bharatividyapeeth(Deemed To Be University) Homoeopathic Medical College And Homoeopathic Hospital

rajendra.shinde@bharatividyapeeth.edu9637206722

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026